Immunicum AB Financial Overview
Immunicum AB's market cap is currently €34.98M. The company's EPS TTM is €-0.03444225; its P/E ratio is -3.45; Immunicum AB is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
